Article
Mutagenic effect of ribavirin on hepatitis C nonstructural 5B quasispecies in vitro and during antiviral therapy.
Gastroenterology - 1 Mar 2007
Hofmann Wolf Peter, Polta Andreas, Herrmann Eva, Mihm Ulrike, Kronenberger Bernd, Sonntag Tanja, Lohmann Volker, Schönberger Barbara, Zeuzem Stefan, Sarrazin Christoph
Abstract excerpt
BACKGROUND AND AIMS: Addition of ribavirin to interferon alfa treatment has substantially increased sustained virologic response rates in patients with chronic hepatitis C (CHC). Ribavirin acts as an RNA virus mutagen in vitro, thereby leading to error catastrophe. However, data in CHC are controversial. METHODS: The nonstructural (NS) 5B quasi-species heterogeneity was analyzed in Huh7 cells harboring a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
